News: Sectors

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors
08/15Bayer Launches ForGround
CI
08/15Lepu Biopharma Co., Ltd. Change of Address of Principal Place of Business in Hong Kong
CI
08/15Hang Chi Holdings Limited Announces Executive Changes
CI
08/15Zhejiang Garden Bio-chemical High-tech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
08/15Zylox-Tonbridge Medical Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
08/15Novartis fails again to reuse anti-inflammatory drug to treat lung cancer
RE
08/15Daewoong Pharmaceutical Announces US FDA Clearance of IND Application for DWP213388, First-In-Class Irreversible Oral Dual Acting Inhibitor for Autoimmune Diseases
CI
08/15RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2022
CI
08/15GNI Group Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 2022
CI
08/15Paragon Care Limited Announces Executive Changes
CI
08/15Genetics Generation Advancement Corp. Announces Cash Dividend, Payable on September 30, 2022
CI
08/15BAYER AG : Bernstein keeps its Buy rating
MD
08/15AstraZeneca-Daiichi's breast cancer drug improves survival in study
RE
08/15Solasia Pharma K.K. Provides Consolidated Financial Guidance for the Fiscal Year Ending December 31, 2022
CI
08/15Inhalation Sciences Sweden AB Announces Resignation of Klaus Gottwald from Its Board of Directors
CI
Discover
08/15Enhertu Significantly Delayed Breast Cancer Progression in Trial, AstraZeneca Says
DJ
08/15H.U. Group Holdings, Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023
CI
08/15ENHERTU® Significantly Delayed Disease Progression in DESTINY-Breast02 Phase 3 Trial Versus Physician’s Choice of Treatment in Patients with HER2 Positive Metastatic Breast Cancer
CI
08/15Abingdon Health plc Announces Resignation of Lyn Rees as Non-Executive Director At the End of September 2022
CI
08/15H.U. Group Holdings, Inc. Provides Dividend Guidance for the Second Quarter and for the Fiscal Year Ended March 31, 2023
CI
08/15Abingdon Health plc Provides Earnings Guidance for the Full Year 2022
CI
08/15Novartis says lung cancer drug canakinumab failed phase III trial
RE
08/15Novartis provides update on Phase III CANOPY-A study evaluating canakinumab as adjuvant treatment in non-small cell lung cancer
DJ
08/15Novartis Provides Update on Phase III CANOPY-A Study Evaluating Canakinumab as Adjuvant Treatment in Non-Small Cell Lung Cancer
CI
08/15Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration for Substance Use Disorders
DJ
08/15Toleranzia Appoints Torbjörn Sannerstedt as New Chief Financial Officer
CI
08/15Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration for Substance Use Disorders
CI
08/15Roche Launches New Diagnostic Test for the Better Understanding of Immune Response to SARS-CoV-2
CI
08/15Medivolve Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15StageZero Life Sciences Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/15Rachanee Yingchairak agreed to acquire Princeton Park Suites Company Limited from Vibhavadi Medical Center Public Company Limited for THB 20 million.
CI
08/15Proteomics International Laboratories Limited announced that it expects to receive AUD 7.9985 million in funding
CI
08/15DELTA 9 CANNABIS INC. (TSX : DN) entered into an asset purchase agreement to acquire all or Substantially all assets of 10552763 Canada Corp. for CAD 3.25 million.
CI
08/15Kubota Pharmaceutical Holdings Co., Ltd. announced that it expects to receive ¥3.1 million in funding from Barclays Bank PLC, Investment Arm
CI
08/15Boston Scientific Corporation acquired Obsidio, Inc.
CI
08/15Sonnet BioTherapeutics Holdings, Inc. announced that it has received $2.25 million in funding
CI
08/15Plus Therapeutics, Inc. authorizes a Buyback Plan.
CI
08/15Irwin Naturals Inc. acquired Assets from Hobie Fuerstman DO PLC.
CI
08/15Hbm Holdings Limited Announces Completion of First Dosing of Last Patient with Hbm4003 Phase Ib Trial
CI
08/15TRANSCRIPT : Caladrius Biosciences, Inc. - Special Call
CI
08/15Certain Series B Preferred Stock of Sunshine Biopharma, Inc. are subject to a Lock-Up Agreement Ending on 15-AUG-2022.
CI
08/15Certain Convertible Notes of Sunshine Biopharma, Inc. are subject to a Lock-Up Agreement Ending on 15-AUG-2022.
CI
08/1556,160 Ordinary Shares of Biome Australia Limited are subject to a Lock-Up Agreement Ending on 15-AUG-2022.
CI
08/15Certain Common Stock of Sunshine Biopharma, Inc. are subject to a Lock-Up Agreement Ending on 15-AUG-2022.
CI
08/15EVOFEM BIOSCIENCES, INC.(OTCPK : EVFM) dropped from S&P TMI Index
CI
08/15RADIUS HEALTH, INC.(NASDAQGM : RDUS) dropped from S&P Biotechnology Select Industry Index
CI
08/15RADIUS HEALTH, INC.(NASDAQGM : RDUS) dropped from S&P Global BMI Index
CI
08/15RADIUS HEALTH, INC.(NASDAQGM : RDUS) dropped from S&P TMI Index
CI
08/14Novartis Phase 3 Canopy-A Trial Didn't Meet Primary Endpoint
DJ
08/14MGC Pharmaceuticals Ltd Provides the Following Results from A Recently Completed Randomised, Double Blind, Placebo Controlled Study Investigating the Effect of MGC's Pharma's Epilepsy Treatment, Cannepil®, on Vehicle Driving Performance, Sedation and Mood
CI
08/14United Orthopedic Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/14Daiichi Sankyo Shares Gain After It Wins Dispute Over Cancer Drug Technology
DJ
08/14Global Health Limited Appoints Robin Armstrong as Regional Chief Executive, Asia Pacific in Singapore
CI
08/14Wattana Karnpaet Public Company Limited Announces Board Changes
CI
08/14Wattana Karnpaet Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/14Opthea Secures up to USD 170 Million in Non-Dilutive Financing for OPT-302 in wet AMD
CI
08/14Chularat Hospital Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/14Careteq Limited Announces Exclusive Agreement with StrongRoom AI
CI
08/14Astra Industrial Group Company Reports Earnings Results for the Second Quarter Ended June 30, 2022
CI
08/14Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Reports Earnings Results for the Half Year Ended June 30, 2022
CI
08/14ChengDa Pharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
08/14Medtecs International Corporation Limited Reports Earnings Results for the Half Year Ended June 30, 2022
CI
08/14Clearbridge Health Limited Reports Earnings Results for the Half Year Ended June 30, 2022
CI
08/14Innovative Eyewear, Inc. has completed an IPO in the amount of $8.382354 million.
CI
08/13Q & M Dental Group Limited Declares No Dividend for the Second Quarter Ended 30 June 2022
CI
Discover
08/13Q & M Dental Group Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/13Plus Therapeutics, Inc. Presents Positive Data from Ongoing ReSPECT™ Clinical Trials at the Annual Conference on CNS Clinical Trials and Brain Metastases
CI
08/13Marksans Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
CI
08/13The European Innovation Council Awards the Acousort Project Acousome SEK 26 Million to Develop Technology for Exosome-Based Diagnostics
CI
08/13U.S. and Switzerland working on facilitating pharma trade - U.S. ambassador
RE
Prev.1  2  3  4  5   6  7  8  9  10Next